Chargement en cours...
Immunotherapy: Who is Eligible?
Recurrent and/or metastatic head and neck cancer portends a poor prognosis with traditional treatments, but current immunotherapy with immune checkpoint inhibitors has the potential to improve these clinical outcomes. This review focuses on the major breakthroughs that have led to our current unders...
Enregistré dans:
| Publié dans: | Otolaryngol Clin North Am |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282181/ https://ncbi.nlm.nih.gov/pubmed/28755708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.otc.2017.04.006 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|